FLI-06

CAS No. 313967-18-9

FLI-06 ( FLI06; FLI 06; FLI06 )

Catalog No. M17475 CAS No. 313967-18-9

FLI-06 is a Notch signaling inhibitor (EC50: 2.3 μM).

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 In Stock
5MG 61 In Stock
10MG 91 In Stock
25MG 163 In Stock
50MG 295 In Stock
100MG 514 In Stock
500MG 1125 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FLI-06
  • Note
    Research use only, not for human use.
  • Brief Description
    FLI-06 is a Notch signaling inhibitor (EC50: 2.3 μM).
  • Description
    FLI-06 is a Notch inhibitor and the early secretory pathway inhibitor. FLI-06 disrupts the Golgi apparatus in a manner distinct from that of brefeldin A and golgicide A. FLI-06 inhibits general secretion at a step before exit from the endoplasmic reticulum (ER), which was accompanied by a tubule-to-sheet morphological transition of the ER. FLI-06 is the first small molecule acting at such an early stage in secretory traffic. Notch signaling has a pivotal role in numerous cell-fate decisions, and its aberrant activity leads to developmental disorders and cancer.
  • Synonyms
    FLI06; FLI 06; FLI06
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Notch
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    313967-18-9
  • Formula Weight
    438.52
  • Molecular Formula
    C25H30N2O5
  • Purity
    98%
  • Solubility
    DMSO : ≥ 38 mg/mL; 86.66 mM
  • SMILES
    CC1=C(C(c2ccc(cc2)[N+](=O)[O-])C2=C(CC(C)(C)CC2=O)N1)C(=O)OC1CCCCC1
  • Chemical Name
    cyclohexyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Krmer A, et al. Nat Chem Biol. 2013, 9(11), 731-738.
molnova catalog
related products
  • Escitalopram Oxalate

    Escitalopram Oxalate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) with Ki of 0.89 nM.

  • GSK620

    GSK620 is a pan-BD2 inhibitor, which shows an anti-inflammatory phenotype in human whole blood with excellent broad selectivity, developability, and in vivo oral pharmacokinetics.

  • UMB298

    UMB298 is a potent and selective CBP/P300 bromodomain inhibitor. UMB298 inhibits BRD4 with IC50 of 5193nM.